The partnering event BioFit2022 took place in Strasbourg, France on November 29th and 30th as well as online on December 7th and 8th. It reflected on challenging times in the pandemic, survivors’ of the economic threats, and adressed the preparation and perseverance needed to deal with challenges today and in the future. The bottom line: dynamic partnerships and more financing opportunities on the horizon.
EIF appointed Chief Executive
AppointmentsAt the beginning of January 2023?Marjut Falkstedt will start as new Chief Executive of the European Investment Fund (EIF).
A ray of hope in leukaemia
Latest NewsA child with recurrent T-cell leukaemia was given base-edited T-cells in a world-first application of a base-edited cell therapy.
Blow-Fill-Seal technology and vaccine delivery
BackgroundUnit-dose?The SARS-CoV2 pandemic caused 6.3 million deaths and contaminated 545 million people across the world. In spite of the rapid development and approval of vaccines, the shortages of consumables like glass vials limited the distribution of prophylactic vaccines. Blow-Fill-Seal (BFS) is an alternative solution with advantages that could play an important role in vaccine distribution worldwide.
Amgen wins race of top `22 deals with $26bn for Horizon thx
Latest NewsAccording to Bloomberg, the US biotechnology giant Amgen plans to buy Horizon Therapeutics at a valuation of about $26bn. Overall, the deal corresponds to an enterprise value including debt of $28.3bn. This would be the largest acquisition in the company’s history.
Have biotech stocks bottomed out?
OpinionBiotechnology was dramatically rewarded in the financial markets through much of 2020 and the first half of 2021, widely credited for providing the COVID-19 vaccines. This followed four already exceptional years in the financial markets, with the Nasdaq Biotech Index (NBI) hitting its all-time high of 5449.32 on 30 August 2021.
Step Pharma presents promising cancer treatment
Latest NewsStep Pharma intruduces promising data on the potential of a selective cancer treatment by inhibition of CTPS1 with their inhibitor STP938.
Partnering revitalized at the BioFit2022 – in Strasbourg and online
Latest NewsThe partnering event BioFit2022 took place in Strasbourg, France on November 29th and 30th as well as online on December 7th and 8th. It reflected on challenging times in the pandemic, survivors’ of the economic threats, and adressed the preparation and perseverance needed to deal with challenges today and in the future. The bottom line: dynamic partnerships and more financing opportunities on the horizon.
Making a better cheese
BackgroundThe French company Standing Ovation uses precision fermentation to create the protein that gives cheese its unique properties. With his pitch, co-founder and CEO Frédéric P’ques took the prize at the start-up pitch of the Industria Biotech.
Affinity Maturation Service
ProductsSino Biological and Ainnocence have joined forces to establish an AI-enabled platform for antibody affinity maturation.
Valneva: New created position
AppointmentsValneva has appointed Dipal Patel as new Chief Commercial Officer and Management Board member.